Privia Health Group (PRVA)
NASDAQ:PRVA
Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$24.02
$0.26(1.28%)
At close: 4:00 PM EST
$24.02
$0.26(1.28%)
Day’s Range― - ―
52-Week Range$18.77 - $26.51
Previous CloseN/A
Volume48.95K
Average Volume (3M)816.29K
Market Cap
$2.90B
Enterprise Value-$407.60B
Total Cash (Recent Filing)$419.52B
Total Debt (Recent Filing)$9.02B
Price to Earnings (P/E)208.4
Beta0.77
Next Earnings
Aug 06, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding126,012,375
10 Day Avg. Volume847,844
30 Day Avg. Volume816,290
Financial Highlights & Ratios
PEG Ratio2.17
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap-140.57
Enterprise Value/Revenue-181.43
Enterprise Value/Gross Profit-1.89K
Enterprise Value/Ebitda-7.78K
Forecast
1Y Price Target
$31.33Price Target Upside30.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)0.26
Revenue Forecast (FY)$2.41B
Bulls Say, Bears Say
Bulls Say
Balance Sheet And Capital AllocationA substantial cash balance with no debt provides flexibility to pursue acquisitions or expand into new markets to compound profitability and support strategic growth.
Technology And MarginsManagement cited deployment of artificial intelligence across clinical and administrative operations as a driver that can raise margins and improve long-term profitability.
Value-based Care ExpansionGrowth in participating providers and in attributed patient lives is increasing practice collections and expanding care margins, supporting stronger operating leverage.
Bears Say
Cash Taxation And GuidanceGuidance reflects more moderate revenue assumptions and lower free cash flow conversion as the company transitions to full cash taxation, which could limit near-term cash generation.
Practice Collections WeaknessPractice collections fell short of expectations, creating top-line pressure and a potential headwind for revenue recognition.
Research ConflictsThe covering firm discloses business relationships with companies it researches, which may create conflicts that could affect the objectivity of analyst reports.
Privia Health Group News
PRVA FAQ
What was Privia Health Group’s price range in the past 12 months?
Privia Health Group lowest stock price was $18.77 and its highest was $26.51 in the past 12 months.
What is Privia Health Group’s market cap?
Privia Health Group’s market cap is $2.90B.
When is Privia Health Group’s upcoming earnings report date?
Privia Health Group’s upcoming earnings report date is Aug 06, 2026 which is in 83 days.
How were Privia Health Group’s earnings last quarter?
Privia Health Group released its earnings results on May 07, 2026. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.075 by -$0.055.
Is Privia Health Group overvalued?
According to Wall Street analysts Privia Health Group’s price is currently Undervalued.
Does Privia Health Group pay dividends?
Privia Health Group does not currently pay dividends.
What is Privia Health Group’s EPS estimate?
Privia Health Group’s EPS estimate is 0.07.
How many shares outstanding does Privia Health Group have?
Privia Health Group has 126,012,375 shares outstanding.
What happened to Privia Health Group’s price movement after its last earnings report?
Privia Health Group reported an EPS of $0.02 in its last earnings report, missing expectations of $0.075. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Privia Health Group?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.33 (30.45% Upside)
$31.33 (30.45% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 397.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.43%
12-Months-Change
Fundamentals
Return on Equity
1.63%
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum — double‑digit provider and attributed‑lives growth, healthy practice collections growth, significant adjusted EBITDA expansion, margin improvement, and successful early integration of Evolent — supported by a large M&A pipeline and clear technology/AI initiatives to drive future efficiency. Offsetting factors included management’s conservative approach to full‑year guidance (except attributed lives), quarter‑to‑quarter volatility from prior‑year adjustments and shared‑savings timing, Q1 seasonality of cash flows, and payer/policy uncertainties (e.g., MA/V28 dynamics and variability in capitated vs. shared‑risk economics). Overall, the positives on growth, profitability, balance sheet flexibility, and execution materially outweighed the cited risks and uncertainties.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
Average Price Target
$31.33
▲(30.45% Upside)
Technical Analysis
Ownership Overview
1.95% Insiders
28.07% Mutual Funds
9.71% Other Institutional Investors
37.29% Public Companies and
Individual Investors